# PROGRESS.md - Session Continuity

> Claude reads this FIRST every session. Run `/archive` when exceeding 100 lines.

**Phase:** 1 - Foundation (Week 1-6 complete, Week 7 in progress)
**Last Updated:** 2026-02-16

## Completed
- Week 1-2: IBKR connection layer (PR #4), smoke test (PR #5), market data subscriptions
- Week 3-4: Local JSON storage (PR #6), IBKR orders (PR #7), income sleeve (PR #8) -- all merged
- Week 5: IBKR option chains, IV rank/percentile, technical indicators, market data service (PR #9)
- Week 6: Options screening service, Polygon.io calendar integration (PR #10, #11)
- Fix: VIX index contract, option chain ConId, delayed data fallback (PR #12)
- Week 7 PR 1: Multi-leg combo orders, OptionsPosition model, JSON repository (PR #13 merged)
- Fix: IBKR error 10167 delayed data warning treated as informational (pushed to main)
- Week 7 PR 2 in progress: lifecycle rules, position grouper, candidate converter, and position sizer implemented on `feature/options-position-lifecycle`

## Blockers
- ~~Polygon.io~~ DONE -- Stocks Starter plan signed up
- Discord Setup: Create server/channel, create webhook URL -- needed Week 10
- Claude API Key: Sign up at console.anthropic.com -- needed Week 9

## Next Session Should
1. Open PR for `feature/options-position-lifecycle` (new lifecycle components + tests)
2. Investigate pre-existing failing test: `JsonIVHistoryRepositoryTests.GetAsync_StaleData_ReturnsNull` (current full run: 391/392)
3. Start PR 3: `feature/options-sleeve-manager` (orchestration and execution flow)

---
<!-- Recent sessions: keep last 3 entries. Older entries -> docs/archive/progress-archive.md -->
- 2026-02-16 Implemented Week 7 PR 2 on `feature/options-position-lifecycle`: added lifecycle rules, position grouping/reconciliation, candidate conversion, and position sizing with options tests passing (143/143).
- 2026-02-12 PR #13 merged + smoke tested 14/14. Fixed error 10167. 361 unit tests. Ready for PR 2.
- 2026-02-12 Completed PR #13: multi-leg BAG orders, OptionsPosition model, JSON repo. 56 new tests.
